Truly Technologies was founded with the mission to innovate biospecimen processing for diagnostics, therapeutics, and life science research. The company focuses on developing advanced bioprocessing solutions that concentrate biomolecules at high yield and purity using osmotic pressure across a semipermeable membrane. Their technology addresses a wide range of bioprocessing challenges, providing a simple and efficient method for both concentration and purification of biomolecules.
Notable figures affiliated with Truly Technologies include experts in biotechnology and life sciences, though specific names are not provided. The company has achieved significant milestones in developing its proprietary technology, which has the potential to revolutionize diagnostic and therapeutic processes. By enhancing the efficiency and effectiveness of biomolecule processing, Truly Technologies is poised to make a substantial impact on the fields of diagnostics and life science research.
